These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 21119625

  • 1. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer.
    Salido E, Rodriguez-Pena M, Santana A, Beattie SG, Petry H, Torres A.
    Mol Ther; 2011 May; 19(5):870-5. PubMed ID: 21119625
    [Abstract] [Full Text] [Related]

  • 2. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
    Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N.
    Transplantation; 2008 May 15; 85(9):1253-60. PubMed ID: 18475180
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential expression of liver and kidney proteins in a mouse model for primary hyperoxaluria type I.
    Hernández-Fernaud JR, Salido E.
    FEBS J; 2010 Nov 15; 277(22):4766-74. PubMed ID: 20977670
    [Abstract] [Full Text] [Related]

  • 7. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
    Li Y, Zheng R, Xu G, Huang Y, Li Y, Li D, Geng H.
    Am J Physiol Renal Physiol; 2021 Mar 01; 320(3):F475-F484. PubMed ID: 33491567
    [Abstract] [Full Text] [Related]

  • 8. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
    Zheng R, Fang X, He L, Shao Y, Guo N, Wang L, Liu M, Li D, Geng H.
    Curr Mol Med; 2018 Mar 01; 18(7):436-447. PubMed ID: 30539697
    [Abstract] [Full Text] [Related]

  • 9. In vivo base editing rescues primary hyperoxaluria type 1 in rats.
    Chen Z, Zhang D, Zheng R, Yang L, Huo Y, Zhang D, Fang X, Li Y, Xu G, Li D, Geng H.
    Kidney Int; 2024 Mar 01; 105(3):496-507. PubMed ID: 38142039
    [Abstract] [Full Text] [Related]

  • 10. CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1.
    Zheng R, Li Y, Wang L, Fang X, Zhang J, He L, Yang L, Li D, Geng H.
    Kidney Int; 2020 Oct 01; 98(4):947-957. PubMed ID: 32464217
    [Abstract] [Full Text] [Related]

  • 11. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
    Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar 01; 300(3):G461-9. PubMed ID: 21163900
    [Abstract] [Full Text] [Related]

  • 12. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
    Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.
    Biochem Biophys Res Commun; 2019 Oct 01; 517(4):677-683. PubMed ID: 31402115
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of new mutations in primary hyperoxaluria type 1 (PH1).
    von Schnakenburg C, Rumsby G.
    J Nephrol; 1998 Oct 01; 11 Suppl 1():15-7. PubMed ID: 9604803
    [Abstract] [Full Text] [Related]

  • 15. Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.
    Tu X, Zhao Y, Li Q, Yu X, Yang Y, Shi S, Ding Z, Miao Y, Zou Z, Wang X, Jiang J, Du D.
    Clin Exp Nephrol; 2019 Jul 01; 23(7):890-897. PubMed ID: 30852714
    [Abstract] [Full Text] [Related]

  • 16. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B.
    Biochim Biophys Acta; 2013 Dec 01; 1832(12):2277-88. PubMed ID: 24055001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of alanine supplementation on oxalate synthesis.
    Wood KD, Freeman BL, Killian ME, Lai WS, Assimos D, Knight J, Fargue S.
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan 01; 1867(1):165981. PubMed ID: 33002578
    [Abstract] [Full Text] [Related]

  • 19. A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.
    Li X, Gu J, Yang Y, Li J, Li Y.
    Tohoku J Exp Med; 2018 Dec 01; 246(4):233-241. PubMed ID: 30541997
    [Abstract] [Full Text] [Related]

  • 20. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.
    Danpure CJ.
    Am J Nephrol; 2005 Dec 01; 25(3):303-10. PubMed ID: 15961951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.